Latest News

Some 0% intro APR cards offer up to 21 months of no interest. Here's how paying just $285 a month can knock out $6,000 in credit card debt.

Opendoor has outperformed the S&P 500 recently, but this could soon change in a big way.

The Shiller CAPE ratio is flashing warning signs.

The pharma stock yields more than 4x the S&P 500 average.

Private credit, like private equity, encompasses a vast array of different assets with equally vast risks.

Since 2023, these stocks have soared between 490% and 2,400%.

Wall Street is bullish on Nvidia's stock.

Nasdaq price prediction based on the technical analysis.

Oracle is one of the biggest names in enterprise software and cloud services. They power databases used by governments, banks, hospitals, airlines, and global corporations.

These funds offer yields that are more than three times the S&P 500 average.

Catalyst Pharmaceuticals offers strong growth, solid profitability, and a debt-free balance sheet, all at an attractive valuation compared to its biotech peers.

AEP stock shows strong technicals and a high-quality breakout setup, trading near 52-week highs with defined entry and stop levels.

Discover the catalysts that could ignite CrowdStrike's next big move and see why analysts believe the stock still has major upside.

Once again, Trump says tariffs can replace the income tax.

The stock has lagged broader equities this year, but patient investors who initiate positions today might be very well rewarded in a decade.

Lucid Group stock is currently high risk, high reward.

Smith & Nephew (SNN) is a value investment in medical devices, with strong profitability, accelerating growth, and attractive valuation metrics.

There are several great deals investors should be taking advantage of.

There's a bit of confusion about how some basic market details have looked this year.

Ryanair stock (RYAAY) appears undervalued with strong fundamentals, offering a potential margin of safety for value investors seeking a bargain in the airline industry.

The raise itself doesn't tell the whole story.

Applied Materials (AMAT) is a top-tier quality stock with strong growth, exceptional 43.7% ROIC, robust cash flow, and a healthy balance sheet for long-term investors.

PepsiCo has numerous strengths. Alas, excellent market performance is not one of them.

If Goldman Sachs is right, investors can position their portfolios accordingly with two Vanguard index funds.